Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). - Wikidata - awgldk - TriplyDB

Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).

Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).

http://www.wikidata.org/entity/Q33756093

about

Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials Intensity-modulated radiotherapy for early glottic cancer: transition to a new standard of care?Decreased radiation doses to tongue with "stick-out" tongue position over neutral tongue position in head and neck cancer patients who refused or could not tolerate an intraoral device (bite-block, tongue blade, or mouthpiece) due to trismus, gag re Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel : a phase II study.Is There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer?Current Role of Surgery in the Management of Oropharyngeal Cancer Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice Radioluminescence characterization of in situ x-ray nanodosimeters: Potential real-time monitors and modulators of external beam radiation therapy Prognostic factors in limited (T1-2, N0-1) oropharyngeal carcinoma treated with surgery ± adjuvant therapy.Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.Institutional clinical trial accrual volume and survival of patients with head and neck cancer.Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy.Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers Dosimetric impact of target definitions on normal structures in head and neck cancer.Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience.Incorporation of Electronic Brachytherapy for Skin Cancer into a Community Dermatology Practice.Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.Credentialing for participation in clinical trials.Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century.Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control.Intensity-modulated radiotherapy in the treatment of locoregionally advanced head and neck cancer: implementation and outcomes in a New Zealand community hospital.Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review IMRT for head and neck cancer: reducing xerostomia and dysphagia.The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study Survival Outcomes and Patterns of Recurrence in Patients with Stage III or IV Oropharyngeal Cancer Treated with Primary Surgery or Radiotherapy.Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional Study Pattern and predictors of volumetric change of parotid glands during intensity modulated radiotherapy.A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy.A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features.Outcome and prognostic factors in T4a oropharyngeal carcinoma, including the role of HPV infection.Clinical heterogeneity and tumor control probability.Adaptive radiation therapy for head and neck cancer-can an old goal evolve into a new standard?Organ-sparing radiation therapy for head and neck cancer.Robotic surgery for oropharynx cancer: promise, challenges, and future directions.Technical advances and pitfalls in head and neck radiotherapy.

P2860

Q26828964-03D498B1-ECD6-417D-B725-B626BFD398BE Q30248571-EFF0EF6D-FD86-42B9-85DB-FD03D83ABB8F Q30363946-A61AE5BA-A918-487E-B25E-86EE246E5B21 Q33397340-C0A56A4B-4A7F-4CDA-89C1-2341219F3BFC Q33652561-8AAD91C0-3192-437D-A08E-3EB611D03163 Q33652572-2861DF5C-62A1-4116-B57A-7A9FB2207A3D Q33809120-611CE070-D42E-4E91-8350-EBEBB18DDA2F Q34228231-4C6CAC1D-08C7-4995-9B7B-B29DD516CFE2 Q34558103-0519A36E-B14C-4566-B842-FDFB3D0117AA Q34610943-FE8C13A8-5D01-4C57-A5AB-7B4EBEBA0328 Q34743124-939FC40F-6A07-40CD-94F6-0D446569F68D Q34786079-5D1F36A8-6195-4BA3-8AB2-9246BE5BF180 Q35081204-B096E7B8-F73A-41E6-8F5E-25AAC96C0E21 Q35142863-0C856D11-A2D7-414B-AE35-F9C4B42018BB Q35203854-52FD1938-F5A4-47CC-A806-BC5FFA3A64A8 Q35534813-93DB8156-C7D6-4D1E-890A-B06D0BDACA2E Q35602115-CDF47A33-6F10-4537-AF75-79399AC1BEB3 Q35878641-2BDE1180-B396-4E1A-BEDA-109796CC590B Q35927872-4490D351-5390-47FD-8606-6DC4DC8CC177 Q36343896-25CEABCC-6CB6-4318-BA7E-CC58D0AA4D75 Q36488383-85D22F17-52CC-45BB-8209-03AE732F4455 Q36621257-476AFCBB-4343-48B9-9571-CD618708A000 Q36914455-A553F747-D707-41AD-89CA-6A3DE9453EEE Q36922981-C2C32089-0D6E-4EB1-96AF-B17178BF8235 Q37023648-55007241-7746-44EE-A2F1-318F08AB7267 Q37110377-8A9BE65F-C46F-451A-A49E-AAA940C9462D Q37187245-3186C088-AEAF-449D-98B1-0873C5E6103E Q37193603-7AC88F1C-5603-450A-B6DC-5A8789B12F1A Q37214324-6F01722D-32C4-4D88-A182-920AB87F03E4 Q37248881-DB676493-E25B-4066-A727-FCD222B201DA Q37314916-F60CB86B-6112-4E49-BA88-02192CDD9CC9 Q37356887-BD5263DF-BD4B-43CE-96B9-4213E0E1E05E Q37586420-FAAC3296-9EF2-4B00-BCE7-F7BBA38F1FEA Q37697240-28A0961D-40F2-4DF6-BD7A-81BFB0C35049 Q37706474-7759793F-3258-4C1A-8CB0-6C1F7FA2F737 Q37760509-DDFCCCAC-E8B9-4BD8-9ACB-6350D768A2B6 Q37789625-6B96AE64-E009-482F-8D3A-E9638931A532 Q37905536-4218EC60-3226-4EBA-A873-396D82A6ADAD Q37981985-A3D4EF7A-0CD5-4047-A581-9C7622ADF030 Q38018950-898839DE-A072-4D05-B063-CB7319F1F5A3

P2860

Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).

http://www.wikidata.org/entity/Q33756093

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Multi-institutional trial of a ...... haryngeal cancer (RTOG 00-22).

@ast

Multi-institutional trial of a ...... haryngeal cancer (RTOG 00-22).

@en

type

label

Multi-institutional trial of a ...... haryngeal cancer (RTOG 00-22).

@ast

Multi-institutional trial of a ...... haryngeal cancer (RTOG 00-22).

@en

prefLabel

Multi-institutional trial of a ...... haryngeal cancer (RTOG 00-22).

@ast

Multi-institutional trial of a ...... haryngeal cancer (RTOG 00-22).

@en

P1433

Q33756093-E94D263F-8D8F-4B91-9631-88515CAB5B5C

P1476

Q33756093-62D667C5-C982-4B7A-92BF-CCC3ED7F57D7

P2093

Q33756093-6AAFEF91-B7C4-44D3-86B2-F1CA7372B827

Q33756093-7F8425E6-6B2C-4BB1-8439-0FF1E58B1E20

Q33756093-8F4D3E74-D782-4AEA-9A6E-150EA0BEF0AF

Q33756093-9486A47C-B911-4B3A-B44D-5A290D8ABC9D

Q33756093-B563096A-84FD-4131-AEE5-40831EC13D99

Q33756093-D29DAF25-394F-4396-9213-1E9F7003BF27

Q33756093-D413740C-4E92-4A10-9F12-19CCE2107275

Q33756093-EBB95BA7-5683-4DD6-BFC8-D112FBE4DF3C

Q33756093-EDA3A759-7783-490C-8556-3469E275A33E

P2860

Q33756093-1CF1F0FD-3268-46FB-8AD9-B3FCF375665E

Q33756093-23806E31-6591-431B-9D2A-D7F3699F82B5

Q33756093-39439046-B645-4B4D-AA12-359D1B313CA7

Q33756093-50E8132C-8B5C-49EC-ABC6-1CF2A633CFCE

Q33756093-575D55BB-59B8-4EC7-8454-E6674EA32451

Q33756093-5BCB7E87-A8AB-459B-84CF-772815F900E1

Q33756093-A0EE2F46-E86B-4A34-84B6-F8B539337A16

Q33756093-A69CFD81-B5CE-45F3-BAD5-7D58AC00091C

Q33756093-CAF8C895-810B-43C9-9D5F-D8AC45AA2AD1

Q33756093-D3F2215F-BD49-4F90-AC35-074448D2D777

P304

Q33756093-6D75C1C6-3755-4779-91D1-D74E4AB1347C

P31

Q33756093-FC5806B8-6D49-4AFD-8580-E50397CDCB32

P356

Q33756093-2B006214-5B0D-40DB-A6AD-A052E44BDF48

P407

Q33756093-7FA05F7E-EB58-442D-8F07-E61F00E2FE7D

P433

Q33756093-B3C49C91-4005-471D-A7EE-CCEC067765B9

P478

Q33756093-D8D37A00-24C7-4723-94CA-3E8EFACBFF67

P50

Q33756093-1A511BC1-892D-495C-9A30-571BA1C8F76F

P577

Q33756093-73AA4111-F31D-479E-B3B1-F8AAFAB0EF03

P5875

Q33756093-37C13A85-11CB-424C-B4C5-3D0CB34EDBFB

P698

Q33756093-74171E7C-1297-49EC-9738-FFA3B55DDB20

P921

Q33756093-CDFEF0C8-301B-4E2D-BBCC-56D40F695772

P932

Q33756093-987BAF12-2182-48F6-8447-1E833A110DF2

P356

J.IJROBP.2009.04.011

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Multi-institutional trial of a ...... haryngeal cancer (RTOG 00-22).

@en

P2093

Adam S Garden

http://www.w3.org/2001/XMLSchema#string

Christopher U Jones

http://www.w3.org/2001/XMLSchema#string

Clifford K S Chao

http://www.w3.org/2001/XMLSchema#string

Giuseppe Sanguineti

http://www.w3.org/2001/XMLSchema#string

Jonathan Harris

http://www.w3.org/2001/XMLSchema#string

K Kian Ang

http://www.w3.org/2001/XMLSchema#string

Paul M Harari

http://www.w3.org/2001/XMLSchema#string

Walter R Bosch

http://www.w3.org/2001/XMLSchema#string

William Straube

http://www.w3.org/2001/XMLSchema#string

P2860

Intensity-modulated radiotherapy: current status and issues of interest

Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma.

Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.

Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research.

Intensity-modulated radiotherapy for head-and-neck cancer in the community setting.

Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions

Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer

Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma.

Design and implementation of an anthropomorphic quality assurance phantom for intensity-modulated radiation therapy for the Radiation Therapy Oncology Group.

P304

1333-1338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2009.04.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Avraham Eisbruch

P577

2009-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26304851

http://www.w3.org/2001/XMLSchema#string

P698

19540060

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

2846217

http://www.w3.org/2001/XMLSchema#string